PDCD1 and melanoma: The study was performed in the experimental syngeneic B16F10 murine melanoma model, which is widely used since it recapitulates salient features of human melanoma [28]: notably, the first indication of efficacy by PD-1 blockade in controlling malignant melanoma was obtained in this model [29].